Global Vaccine Market Forecast to 2012

Table of Contents

1. Analyst View

2. The Global Vaccine Market

• 2.1 Introduction
• 2.2 Market Opportunity Assessment

3. Critical Success & Risk Factors

• 3.1 Critical Success Factors
  • 3.1.1 Disease Prevention
  • 3.1.2 Higher Margins
  • 3.1.3 Support from Government & NGOs
  • 3.1.4 Blockbuster Potential of New Vaccines
  • 3.1.5 Increasing Population in Developing Countries
  • 3.1.6 Disease Awareness
• 3.2 Critical Risk Factors
  • 3.2.1 Huge R&D Cost
  • 3.2.2 Lack of Infrastructure for Trials & Manufacturing
  • 3.2.3 Effective Vaccine Design
  • 3.2.4 Vaccine Supply

4. Major Vaccine Segments

• 4.1 Basic Pediatrics
• 4.2 Enhanced Pediatrics
• 4.3 Proprietary Pediatrics
• 4.4 Adult/Travel Vaccines
• 4.5 Cancer Vaccines
• 4.6 Addiction Vaccines
• 4.7 Influenza Vaccines

5. Major Pediatric Vaccines

• 5.1 Pneumococcal Vaccines
• 5.2 Polio Vaccines
• 5.3 Varicella Vaccines
• 5.4 Meningitis Vaccines
• 5.5 Rotavirus Vaccines
• 5.6 DTP Vaccines
• 5.7 Measles, Mumps & Rubella (MMR) Vaccines
• 5.8 Tuberculosis Vaccines

6. Major Adult/Travel & Therapeutic Vaccines

• 6.1 Hepatitis B Vaccines
• 6.2 Malaria Vaccines
• 6.3 Japanese Encephalitis Vaccines
• 6.4 Ebola Vaccines
• 6.5 Cervical Cancer Vaccines
• 6.6 Typhoid Vaccines
• 6.7 West Nile Vaccines
• 6.8 HIV Vaccines

7. Key Geographical Markets

• 7.1 US
• 7.2 Europe
• 7.3 China
• 7.4 India
• 7.5 Japan
• 7.6 Brazil

8. Competitive Landscape to 2012

• 8.1 Revenues & Growth of Key Players
• 8.2 Revenues & Growth of Key Vaccine Brands
• 8.3 Key Mergers & Acquisitions
• 8.4 Major Categories of Players
  • 8.4.1 Vaccine Majors
  • 8.4.2 Vaccine-focused Biotech Companies
  • 8.4.3 Domestic-focused Vaccine Companies
• 8.5 Key Company Profiles
  • 8.5.1 Sanofi-Aventis
  • 8.5.2 GlaxoSmithKline Plc.
  • 8.5.3 Merck & Co., Inc.
  • 8.5.4 Novartis
  • 8.5.5 Wyeth

List of Figures:

• Figure 2-1: Vaccines Horizon* (1960 to 2010)
• Figure 2-2: Global - Vaccine Market (in Million US$), 2005-2007
• Figure 2-3: Global - Forecast for Vaccine Market (in Million US$), 2008-2012
• Figure 3-1: Global - Profit Margin of Vaccines, Generics & Branded Drugs (%), 2007E
• Figure 3-2: Global - Vaccine Market by Source of Funding (%), 2001
• Figure 3-3: Global - Prevnar Sales (in Million US$), 2003-2007
• Figure 3-4: Global - Dose Consumption & Revenue by Regional Income (%), 2005
• Figure 4-1: Global - Vaccine Market by Segment (%), 2005-2007
• Figure 4-2: Global - Forecast for CAGR of Vaccine Market by Segment (%), 2007 to 2012
• Figure 4-3: Global - Forecast for Vaccine Market by Segment (%), 2008-2012
• Figure 4-4: Global - Basic Pediatric Vaccine Market (in Million US$) 2005-2007
• Figure 4-5: Global - Forecast for Basic Pediatric Vaccine Market (in Million US$), 2008-2012
• Figure 4-6: Global - Enhanced Pediatric Vaccine Market (in Million US$) 2005-2007
• Figure 4-7: Global - Forecast for Enhanced Pediatric Vaccine Market (in Million US$), 2008-2012
• Figure 4-8: Global - Proprietary Pediatrics/Adolescent Vaccine Market (in Million US$), 2005-2007
• Figure 4-9: Global - Forecast for Proprietary Pediatrics/Adolescent Vaccine Market (in Million US$), 2008-2012
• Figure 4-10: Global - Adult/Travel Vaccine Market (in Million US$), 2005-2007
• Figure 4-11: Global - Forecast for Adult/Travel Vaccine Market (in Million US$), 2008-2012
• Figure 4-12: Global - Cancer Vaccine Market (in Million US$) 2006 & 2007E
• Figure 4-13: Global - Cancer Vaccine by Type in Various Phases of Clinical Development (in Number), Aug 2005
• Figure 4-14: Global - Forecast for Cancer Vaccine Market (in Million US$), 2008-2012
• Figure 4-15: Global - Forecast for Addiction Vaccine Market (in Million US$), 2008-2012
• Figure 4-16: Global - Influenza Vaccine Market (in Million US$), 2005-2007
• Figure 4-17: Global - Influenza Vaccine Production by Manufacturer (%), 2006
• Figure 4-18: Global - Forecast for Influenza Vaccine Market (in Million US$), 2008-2012
• Figure 5-1: Global - Pipeline for Pneumococcal Vaccines
• Figure 5-2: Global - Pneumococcal Vaccine Market (in Million US$), 2007 & 2012F
• Figure 5-3: Global - Number of Polio Incidences (2004-2007)
• Figure 5-4: Global - Countries with Maximum Number of Polio Incidences (2006)
• Figure 5-5: Global - Polio Vaccine Market (in Million US$), 2004 & 2011F
• Figure 5-6: Global - Inactivated Polio Vaccine Doses (in Million), 2006* & 2011F
• Figure 5-7: Global - Meningitis Vaccine Market (in Billion US$), 2004 & 2010F
• Figure 5-8: Global - Forecast for Rotavirus Vaccine Market (in Billion US$), 2010
• Figure 5-9: Global - Forecast for Rotavirus Vaccine Market by Region (%), 2010
• Figure 5-10: Global - Number of Diphtheria Incidences by Region (2007)
• Figure 5-11: Global - Number of Pertussis Incidences by Region (2007)
• Figure 5-12: Global - Number of nTetanus Incidences by Region (2007)
• Figure 5-13: Global - Number of tTetanus Incidences by Region (2007)
• Figure 5-14: Global - DTP Combos Market by Player (%), 2004
• Figure 5-15: Global - Number of Measles Incidences by Region (2007)
• Figure 5-16: Global - Number of Mumps Incidences by Region (2007)
• Figure 5-17: Global - Number of Rubella Incidences by Region (2007)
• Figure 5-18: Global - Number of Tuberculosis Incidences by Region (in ‘000), 2006
• Figure 6-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2006
• Figure 6-2: Global - Hepatitis B Vaccine Market (in Million US$), 1999, 2005, 2006 & 2011F
• Figure 7-1: Global - Vaccine Market by Region (%), 2007E
• Figure 7-2: Global - Forecast for Vaccine Market by Region (%), 2012
• Figure 7-3: Global - Sales Split of Major Vaccine Players by Region (%), 2004
• Figure 7-4: US - Vaccine Market (in Billion US$), 2003, 2007E, 2008F & 2013F
• Figure 7-5: US - Pediatric Vaccine Market (in Billion US$), 2003, 2007E, 2008F & 2013F
• Figure 7-6: US - Hepatitis Vaccine Market (in Million US$), 2003, 2007E, 2008F & 2013F
• Figure 7-7: US - Biodefense Vaccine Market (in Million US$), 2003, 2007E, 2008F & 2013F
• Figure 7-8: US - Influenza Vaccine Market (in Million US$), 2003, 2007E, 2008F & 2013F
• Figure 7-9: US - Travel Vaccine Market (in Million US$), 2003, 2007E, 2008F & 2013F
• Figure 7-10: US - Forecast for Developmental Vaccine Market (in Million US$), 2008 & 2013
• Figure 7-11: Europe - Vaccine Market (in Million US$), 1996, 2005, 2007E & 2012F
• Figure 7-12: China - Vaccine Market (in Million US$), 2006 & 2007E
• Figure 7-13: China - Forecast for Vaccine Market (in Million US$), 2008-2012
• Figure 7-14: India - Vaccine Market (in Billion INR) 2005- 06 to 2007-08E
• Figure 7-15: India - Share of Major Players in Vaccine Market (%), 2006-07
• Figure 7-16: India - Share of Public & Private Sectors in Vaccine Market (%), Nov 2006
• Figure 7-17: India - Share of Domestic Consumption & Exports in Vaccine Market (%), 2005-06
• Figure 7-18: India - Forecast for Vaccine Market (in Billion INR), 2008-09 to 2012-13
• Figure 7-19: Japan - Vaccine Market (in Million US$) 1996, 2005 & 2007E
• Figure 7-20: Japan - Influenza Vaccine Production (in Million Doses), 2004-05 to 2006-07E
• Figure 7-21: Japan - Forecast for Vaccine Market (in Million US$), 2008-2012
• Figure 7-22: Brazil - Vaccine Market (in Million BRL), 2000, 2004, 2007E, 2008F & 2012F
• Figure 7-23: Brazil - Share of Public & Private Sectors in Vaccine Market (%), 2004
• Figure 8-1: Global - Share of Major Players in Vaccine Market (%), 2007
• Figure 8-2: Global - Forecast for Share of Major Players in Vaccine Market (%), 2012
• Figure 8-3: Global - Forecast for CAGR of Major Players in Vaccine Market (%), 2007 to 2012

List of Tables:

• Table 2-1: Global - Revenues* & Growth of Major Therapy Areas (in Million US$), 2007 & 2012F
• Table 3-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines (in ‘000), 2001
• Table 4-1: Global - List of Launched & Under-development Cancer Vaccines by Indiaction
• Table 6-1: Global - Number of HIV/AIDS Patients (2007)
• Table 7-1: China - Vaccine Classification
• Table 7-2: China - Pediatric Vaccine Doses Requirement (in Million)
• Table 7-3: Brazil - Vaccine Market by Public & Private Sectors (in Million BRL), 2000
• Table 8-1: Global - Top Launched Vaccine Brand Sales (in Million US$), 2007 & 2012F
• Table 8-2: Global - Forecast for Top Vaccine Brand Sales Under-development (in Million US$), 2012
• Table 8-3: Global - Key Mergers & Acquisitions in Vaccine Market (2005 to 2008)
• Table 8-4: Global - Major Vaccine Companies (Segmentation by Revenue)